EQT’s $654 million Offering to acquire Karo Pharma

White & Case LLP is advising leading global investment firm EQT, through EQT VIII and Karo Intressenter AB, on the public cash offer to the shareholders…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Paolo Bossi

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here